Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
95%
Ethylenediaminetetraacetic Acid
92%
Heparin
83%
Midazolam
83%
Ultra High Performance Liquid Chromatography
58%
Observational Study
41%
Rifampicin
41%
Clarithromycin
41%
Clavulanic Acid
41%
Drug Metabolism
41%
Glucuronide
41%
Linezolid
41%
Critical Illness
41%
Metformin
41%
Iohexol
41%
Anidulafungin
41%
Piperacillin Plus Tazobactam
41%
Pig
41%
Extensively Drug-Resistant Tuberculosis
41%
Piperacillin
41%
Ertapenem
41%
Caspofungin
41%
Multi-Drug-Resistant Tuberculosis
24%
14 Hydroxyclarithromycin
23%
Cell Marker
20%
Adenosine Triphosphate
20%
Pathophysiology
20%
Therapeutic Drug Monitoring
16%
Minimum Inhibitory Concentration
16%
CYP3A4
11%
Adverse Event
9%
Active Metabolite
8%
Sedative
8%
Beta Lactam Antibiotic
8%
Drug-Drug Interaction
8%
Drug Concentration
8%
Systemic Mycosis
8%
Anesthetic Agent
8%
Pharmacodynamics
8%
TSQ
8%
Aculeacin A
8%
Echinocandin
8%
Mycobacteria
5%
High Performance Liquid Chromatography
5%
Drug Interaction
5%
Dose Fractionation
5%
Efficacy Study
5%
Clinical Trial
5%
Combination Drug
5%
Carbapenem Derivative
5%
Keyphrases
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
43%
Human Plasma
41%
Extensively Drug-resistant Tuberculosis
41%
Perfusion Model
41%
4-hydroxymidazolam
41%
Plasma Ultrafiltrates
41%
Dapagliflozin
41%
Porcine
41%
Human Urine
41%
Empagliflozin
41%
Anidulafungin
41%
Normothermic
41%
Canagliflozin
41%
Kidney Perfusion
41%
MS Method
41%
Metformin
41%
Rapidly Growing Mycobacteria
41%
Sterilizing Effect
41%
Simultaneous Quantification
41%
Inhaler Education
41%
14-Hydroxyclarithromycin
23%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
20%
Expansion Media
17%
Human EDTA Plasma
16%
Normothermic Machine Perfusion
13%
UPLC™
13%
Pharmacokinetic Study
13%
Iohexol Clearance
8%
Intermittent Dosing
8%
Porcine Kidney
7%
Precipitating Agent
6%
Sampling numbers
6%
Type 2 Diabetes Prevention
6%
Acetonitrile
6%
Acetate
6%
Mass Spectrometry Analysis
6%
Renoprotective Effect
6%
Electrospray
6%
Rapid Analysis
6%
Mobile Phase
6%
Adduction
6%
Methanol
6%
Gradient Elution
6%
Cardioprotection
6%
Chromatographic Separation
6%
FDA Guidance
6%
Ammonium Acetate
6%
Biomedical Analysis
6%
Negative Ionization
6%
Glucose-lowering Drugs
6%
Chemistry
Tandem Mass Spectrometry
100%
Liquid Chromatography Mass Spectrometry
58%
Ethylenediaminetetraacetic Acid
50%
Mass Spectrometry
48%
Heparin
41%
Liquid Chromatography
41%
Iohexol
41%
Liquid Chromatography Tandem Mass Spectrometry
41%
Ultra High Performance Liquid Chromatography
41%
Anidulafungin
41%
Moxifloxacin
41%
Lithium
41%
Caspofungin
41%
Dapagliflozin
41%
Canagliflozin
41%
Empagliflozin
41%
Pharmacokinetics
29%
Bioanalytical Method
15%
Ultra Performance Liquid Chromatography
13%
Analytical Calibration
12%
Protein Precipitation
8%
Ambient Reaction Temperature
8%
Aculeacin A
8%
Structure
8%
Echinocandin
8%
Mass Spectrometry
6%
Electrospray
6%
Ammonium Acetate
6%
Acetonitrile
6%
Flow Kinetics
6%
Quadrupole
6%
Gradient Elution
6%
Mobile Phase Composition
6%
Chromatography
6%
Liquid Chromatography Mass Spectrometry (LCMS)
6%
Dilution
6%
Renoprotective
6%
Methanol
6%